SCHEMBL13664189

SCHEMBL13664189

Cc1ccc(C(=O)c2nn(-c3c(C)cc(Cl)cc3C)c(N)c2C#N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
MAPT P10636 6/20 0.41
LMNA P02545 3/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13664187 0.89 MAPT (0.40) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13667701 0.85 CNR1 (0.40) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664161 0.84 MAPT (0.51) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664167 0.83 MAPT (0.50) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664195 0.83 KDM4E (0.50) ALDH1A1MAPTLMNAKMT2AMEN1
SCHEMBL13664173 0.82 MAPT (0.55) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664184 0.81 CNR1 (0.40) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664200 0.81 MAPT (0.42) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664169 0.80 ALDH1A1 (0.46) ALDH1A1MAPTLMNAHPGDKMT2A
SCHEMBL13664172 0.79 MAPT (0.64) ALDH1A1MAPTLMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists MERCK SHARP & DOHME CORP. 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253673-A1 Substituted Pyrazoles as Ghrelin Receptor Antagonists GIPR, GPR119, GLP1R ALDH1A1 3415/4885MAPT 4701/4885LMNA 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.